D. Kennedy

Most-cited papers

Patient-reported outcomes to support medical product labeling claims: FDA perspective.
D.walaa badawy, L. Burke, J. Powers, Jane A. Scott +4 more
2007Value in Health712 citations Open access
Semantic Scholar
Antibiotic Use in Pregnancy and Lactation: What Is and Is Not Known About Teratogenic and Toxic Risks
G. G. Nahum, K. Uhl, D. Kennedy
2006Obstetrics and Gynecology237 citations
Semantic Scholar
Utilization of nonsteroidal antiinflammatory drugs.
C. Baum, D. Kennedy, M. B. Forbes
1985Arthritis & Rheumatism180 citations Open access
Semantic Scholar
Noncontraceptive estrogens and progestins: use patterns over time.
D. Kennedy, C. Baum, M. B. Forbes
1985Obstetrics and Gynecology143 citations
Semantic Scholar
Prescribing of noncontraceptive estrogens and progestins in the United States, 1974-86.
E. Hemminki, D. Kennedy, C. Baum, S. Mckinlay
1988American Journal of Public Health140 citations Open access
Semantic Scholar
Spontaneous Reporting in the United States
D. Kennedy, S. Goldman, Ralph B. Lillie
2002117 citations Open access
Semantic Scholar
Drug use in the United States in 1981.
C. Baum, D. Kennedy, M. B. Forbes, Judith K. Jones
1984Journal of the American Medical Association (JAMA)111 citations
Semantic Scholar
Oral contraceptives in the United States: trends in content and potency.
J. M. Piper, D. Kennedy
1987International Journal of Epidemiology70 citations
Semantic Scholar
Pregnancy Exposure Registries
D. Kennedy, K. Uhl, S. Kweder
2004Drug Safety61 citations
Semantic Scholar
Patient-reported outcomes supporting anticancer product approvals.
E. Rock, D. Kennedy, Melissa H Furness, William F. Pierce +2 more
2007Journal of Clinical Oncology59 citations
Semantic Scholar
Medications and the Safety of the Older Driver: Is There a Basis for Concern?
W. Ray, J. Gurwitz, M. Decker, D. Kennedy
1992Human Factors59 citations
Semantic Scholar
Prescription Drug Use in 1984 and Changes Over Time
C. Baum, D. Kennedy, D. Knapp, J. Juergens +1 more
1988Medical Care58 citations
Semantic Scholar
Drug use and expenditures in 1982.
C. Baum, D. Kennedy, M. B. Forbes, Judith K. Jones
1985Journal of the American Medical Association (JAMA)55 citations
Semantic Scholar
Trends in Use of Oral Hypoglycemic Agents 1964–1986
D. Kennedy, J. M. Piper, C. Baum
1988Diabetes Care45 citations
Semantic Scholar
Evolution of Clinical Trials for Irritable Bowel Syndrome: Issues in End Points and Study Design
Ann Marie Trentacosti, Ru-Yi He, L. Burke, D. Griebel +1 more
2010American Journal of Gastroenterology42 citations
Semantic Scholar
Risk Management Strategies in the Physicians’ Desk Reference Product Labels for Pregnancy Category X Drugs
K. Uhl, D. Kennedy, S. Kweder
2002Drug Safety41 citations
Semantic Scholar
Outpatient antiarrhythmic drug use from 1970 through 1986.
L. Hine, Thomas P. Gross, D. Kennedy
1989Archives of Internal Medicine30 citations
Semantic Scholar
Challenges to use of health-related quality of life for Food and Drug Administration approval of anticancer products.
E. Rock, Jane A. Scott, D. Kennedy, R. Sridhara +2 more
2007Journal of the National Cancer Institute. Monographs29 citations Open access
Semantic Scholar
Drug therapy for ambulatory pediatric patients in 1979.
D. Kennedy, M. B. Forbes
1982Pediatrics29 citations
Semantic Scholar
Information on medication use in pregnancy.
K. Uhl, D. Kennedy, S. Kweder
2003American Family Physician19 citations
Semantic Scholar
Maternal use of prescribed drugs associated with recognized fetal adverse drug reactions.
J. M. Piper, C. Baum, D. Kennedy, P. Price
1988American Journal of Obstetrics and Gynecology16 citations
Semantic Scholar
Adverse Drug Reactions and the Food and Drug Administration
K. Pearson, D. Kennedy
198915 citations
Semantic Scholar
Relationship of oral contraceptive estrogen dose to age.
S. V. VanDecarr, D. Kennedy, F. Rosa, C. Anello +1 more
1983American Journal of Epidemiology15 citations
Semantic Scholar
Antibiotic use in U.S. Hospitals in 1981
D. Kennedy, M. B. Forbes, C. Baum, Judith K. Jones
198315 citations
Semantic Scholar
Monitoring of adverse drug events in hospitals.
D. Kennedy, Joyce M. Johnson, S. Nightingale
1991Journal of the American Medical Association (JAMA)13 citations
Semantic Scholar
Risk minimization practices for pregnancy prevention: understanding risk, selecting tools
K. Uhl, A. Trontell, D. Kennedy
2007Pharmacoepidemiology and Drug Safety11 citations
Semantic Scholar
Prescription drug use before and during pregnancy in a medicaid population
J. M. Piper, C. Baum, D. Kennedy
198810 citations
Semantic Scholar
MedWatch: FDA's Medical Products Reporting Program.
S. Goldman, D. Kennedy
1998Postgraduate medicine9 citations
Semantic Scholar
[Medications and breastfeeding].
K. Uhl, D. Kennedy, Sandra Kweeder
2002Gaceta Médica de México8 citations Open access
Semantic Scholar
Drug Utilization in Norway during the 1970's—Increases, Inequalities, Innovations
D. Kennedy
19847 citations
Semantic Scholar
Disease modifying antirheumatic drugs and pregnancy.
K. Uhl, D. Kennedy, W. Gilliland
2004Journal of Rheumatology5 citations
Semantic Scholar
Complex Clinical, Legal, and Ethical Issues of Pregnant and Postpartum Women as Subjects in Clinical Trials
K. Uhl, M. Miller, D. Kennedy
2004Journal of Women's Health5 citations
Semantic Scholar
MedWatch: FDA's New Medical Products Reporting Program
D. Kessler, D. Kennedy
1993Journal of Clinical Engineering3 citations
Semantic Scholar
Alternatives to Intravenous Tetracycline Hydrochloride for Malignant Pleural Effusions
T. Grasela, C. Walawander, H. Jolson, D. Kennedy
1994The Annals of Pharmacotherapy2 citations
Semantic Scholar
FDA-State Projects to Improve Reporting of Adverse Drug Reactions
D. Kennedy, T. Perez, G. Faich
19902 citations
Semantic Scholar
Judging risks versus benefits of oral contraceptives.
J. Jones, D. Kennedy, J. M. Piper, F. Rosa
1984Clinical Pharmacist2 citations
Semantic Scholar
Estrogens and Endometrial Cancer
D. Kennedy
19802 citations
Semantic Scholar
Accurate information on drug effects on pregnancy is crucial.
K. Uhl, D. Kennedy, S. Kweder
2003American Family Physician1 citations
Semantic Scholar
Monitoring for adverse drug events.
D. Kennedy, S. Goldman
1997American Family Physician1 citations
Semantic Scholar
National adverse drug event reporting.
D. Kennedy, L. Tanner, D. Barash, Roger A. Goetsch
1993American journal of hospital pharmacy1 citations
Semantic Scholar
International Collaboration in Drug Utilization Research
D. Kennedy
1982Drug Intelligence & Clinical Pharmacy1 citations
Semantic Scholar
Improving Patient Care
Gale G. White, M. Weick-Brady, S. Goldman, Thomas P. Gross +4 more
20190 citations
Semantic Scholar
From 1970 Through 1986
L. Hine, T. Gross, D. Kennedy
20170 citations
Semantic Scholar
Medications and breastfeeding.
K. Uhl, D. Kennedy, S. Kweeder
2002American Family Physician0 citations
Semantic Scholar
Judging risks versus benefits of oral contraceptives [editorial]
Judith K. Jones, D. Kennedy, J. M. Piper, Rosa Fw
19840 citations
Semantic Scholar
Propoxyphene: an example of the need for increased pharmacist/patient interaction.
D. Kennedy, L. Burke
1979American Pharmacy0 citations
Semantic Scholar
Propoxyphene:An Exanlple of the Need for Increased Phannacist/Patient Interaction
D. Kennedy, L. Burke
19790 citations
Semantic Scholar
New study linking estrogen use and uterine cancer was hailed.
D. Kennedy
1979Drug research reports0 citations
Semantic Scholar